Literature DB >> 15863434

Spermatozoal nuclear determinants of reproductive outcome: implications for ART.

Emre Seli1, Denny Sakkas.   

Abstract

A male factor is implicated in more than 50% of couples treated with IVF. However, neither the routine testing of male fertility potential nor its treatment address the specific mechanisms by which spermatozoal factors may impact upon reproductive outcome. An important function of spermatozoa is to deliver the paternal genome to the oocyte. Recently, a number of acquired spermatozoal nuclear factors that may have implications on reproductive outcome have been described. These include non-specific DNA strand breaks, numerical abnormalities in spermatozoal chromosome content, Y chromosome microdeletions and alterations in the epigenetic regulation of paternal genome. The exact mechanisms by which these factors affect reproduction are unknown and their implications for assisted reproduction technology outcome need to be further investigated. These recent findings point to the need for novel and more personalized approaches to test and treat male factor infertility.

Entities:  

Mesh:

Year:  2005        PMID: 15863434     DOI: 10.1093/humupd/dmi011

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  24 in total

1.  Correlation of sperm DNA damage with IVF and ICSI outcomes: a systematic review and meta-analysis.

Authors:  Zhongxiang Li; Liquan Wang; Jie Cai; Hefeng Huang
Journal:  J Assist Reprod Genet       Date:  2006-10-04       Impact factor: 3.412

2.  Detection of DNA fragmentation and meiotic segregation in human with isolated teratozoospermia.

Authors:  Sonia Brahem; Meriem Mehdi; Hatem Elghezal; Ali Saad
Journal:  J Assist Reprod Genet       Date:  2010-09-25       Impact factor: 3.412

3.  [Male fertility disorders. An actual and practical review].

Authors:  J Denil
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

4.  Sperm chromatin condensation defects, but neither DNA fragmentation nor aneuploidy, are an independent predictor of clinical pregnancy after intracytoplasmic sperm injection.

Authors:  C Bichara; B Berby; A Rives; F Jumeau; M Letailleur; V Setif; L Sibert; C Rondanino; Nathalie Rives
Journal:  J Assist Reprod Genet       Date:  2019-07-09       Impact factor: 3.412

Review 5.  Sperm DNA damage in male infertility: etiologies, assays, and outcomes.

Authors:  Ryan T Schulte; Dana A Ohl; Mark Sigman; Gary D Smith
Journal:  J Assist Reprod Genet       Date:  2009-12-12       Impact factor: 3.412

6.  Nuclear organisation of sperm remains remarkably unaffected in the presence of defective spermatogenesis.

Authors:  Dimitris Ioannou; Eric J Meershoek; Dimitra Christopikou; Michael Ellis; Alan R Thornhill; Darren Karl Griffin
Journal:  Chromosome Res       Date:  2011-09-27       Impact factor: 5.239

7.  Sperm DNA fragmentation assay by sperm chromatin dispersion (SCD): correlation between DNA fragmentation and outcome of intracytoplasmic sperm injection.

Authors:  T Sivanarayana; Ch Ravi Krishna; G Jaya Prakash; K M Krishna; K Madan; G Sudhakar; G A Rama Raju
Journal:  Reprod Med Biol       Date:  2013-09-01

Review 8.  Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes.

Authors:  Ashok Agarwal; Reda Z Mahfouz; Rakesh K Sharma; Oli Sarkar; Devna Mangrola; Premendu P Mathur
Journal:  Reprod Biol Endocrinol       Date:  2009-12-05       Impact factor: 5.211

9.  Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes--multicenter, double-blinded and randomized controlled trial.

Authors:  K C Worrilow; S Eid; D Woodhouse; M Perloe; S Smith; J Witmyer; K Ivani; C Khoury; G D Ball; T Elliot; J Lieberman
Journal:  Hum Reprod       Date:  2012-11-30       Impact factor: 6.918

Review 10.  Spermatozoal sensitive biomarkers to defective protaminosis and fragmented DNA.

Authors:  Roxani Angelopoulou; Konstantina Plastira; Pavlos Msaouel
Journal:  Reprod Biol Endocrinol       Date:  2007-08-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.